WASHINGTON GROWTH STRATEGIES LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2044575 WASHINGTON, DC

Position in GILD

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$386,853

New position

Shares Held

3,062

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.48%

of 13F equity value

Holder Rank

#1,514

of 2,266 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

WASHINGTON GROWTH STRATEGIES LLC holds $1,904,465 across 3 Drug Manufacturers - General names. GILD ranks #3 (20.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	4,299	$1,081,800
2	JNJ	Johnson & Johnson	1,716	$435,812
3	GILD	Gilead Sciences, Inc. This page	3,062	$386,853

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$386,853	3,062	—	Shares	Sole	2026-07-16
No filing history on record for this holder in this stock.